tiprankstipranks
Advertisement
Advertisement
Nexsen Advances U.S. FDA Pathway and Global Rollout for StrepSure Rapid GBS Test
PremiumCompany AnnouncementsNexsen Advances U.S. FDA Pathway and Global Rollout for StrepSure Rapid GBS Test
4M ago
Nexsen Wins HK$6m Grant to Build Hong Kong Hub for Asia-Pacific StrepSure Rollout
Premium
Company Announcements
Nexsen Wins HK$6m Grant to Build Hong Kong Hub for Asia-Pacific StrepSure Rollout
5M ago
Nexsen maps global rollout for rapid GBS test StrepSure
Premium
Company Announcements
Nexsen maps global rollout for rapid GBS test StrepSure
5M ago
Nexsen Expands GBS Diagnostic Platform into Neonatal Care with AEA-Funded Project
PremiumCompany AnnouncementsNexsen Expands GBS Diagnostic Platform into Neonatal Care with AEA-Funded Project
7M ago
Nexsen to Release 20.2 Million Escrowed Shares to ASX in February
Premium
Company Announcements
Nexsen to Release 20.2 Million Escrowed Shares to ASX in February
7M ago
Nexsen Accelerates US Entry for Rapid GBS Test with FDA Pre-Submission and Leadership Boost
Premium
Company Announcements
Nexsen Accelerates US Entry for Rapid GBS Test with FDA Pre-Submission and Leadership Boost
8M ago
Nexsen Limited Accelerates US Market Entry with MCRA Appointment
PremiumCompany AnnouncementsNexsen Limited Accelerates US Market Entry with MCRA Appointment
10M ago
Nexsen Limited’s ASX Debut and Diagnostic Innovations Propel Growth
Premium
Company Announcements
Nexsen Limited’s ASX Debut and Diagnostic Innovations Propel Growth
10M ago
Nexsen Limited Announces 2025 Annual General Meeting Details
Premium
Company Announcements
Nexsen Limited Announces 2025 Annual General Meeting Details
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100